Molecular Tumor Board: 58-year-old female with intrahepatic cholangiocarcinoma and FGFR2 fusion
In this Molecular Tumor Board, we review a case of intrahepatic cholangiocarcinoma with an FGFR2 fusion. We provide an overview of the different subtypes, risk factors, and prognosis of cholangiocarcinoma. We’ll also discuss recent developments of targeted therapies including FGFR inhibitors that have improved the outlook for patients with this cancer.